Navigation Links
QRxPharma Doses First Patients in Phase III Clinical Trial Program for its 'Dual Opioid' Pain Therapy
Date:11/26/2007

First study to focus on acute, post-surgical pain, with a follow-on safety extension trial to begin in late-2007

SYDNEY, Australia, Nov. 26 /PRNewswire-FirstCall/ -- QRxPharma (ASX: QRX) announced today that a number of patients have been treated in the first of several clinical studies to be conducted as part of the Phase III development program for its lead product candidate Q8003IR, an immediate release dual-opioid pain therapy.

The initial clinical trial is a double-blind, placebo-controlled study designed to compare the efficacy and safety of four different dosage strengths of Q8003IR vs. placebo in a post-surgery, acute pain setting. The study is being conducted at 8 US clinical research sites and is targeted to enroll 250 patients experiencing moderate to severe pain following a scheduled surgical procedure (bunionectomy).

"Initiation of this Phase III clinical trial program not only demonstrates the Company's ability to deliver on its development milestones for Q8003IR in terms of budget and time-line projections, but also represents a significant step forward towards our goal of commercializing our first dual-opioid pain therapy in 2010," said Dr. John Holaday, Managing Director and Chief Executive Officer, QRxPharma.

The primary clinical endpoints for this acute, post-surgery pain study focus on pain relief and pain intensity scores vs. placebo over the first 48 hours post-surgery. Secondary endpoints include: (1) efficacy relating to the time to onset of analgesia and the duration of effect from a single oral dose; and (2) safety as measured by the incidence and intensity of opioid-related adverse events. A safety extension trial will immediately follow patient enrollment in this first trial to begin capturing longer-term patient safety data in support of our planned future New Drug Application (NDA) data submission package for Q8003IR.

Q8003IR is a patent-protected, immediate release dual-opioid product
'/>"/>

SOURCE QRxPharma
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
3. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
6. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
7. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
8. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
9. Tainted Chinese Food Ingredients First Discovered in 2005
10. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/mp95jv/global_hearing ... "Global Hearing Aids Market 2015-2019" report to ... aids market to grow at a CAGR of ... Factors such as changing demographics and high prevalence ... market has witnessed immense technological advances. These factors, ...
(Date:7/28/2015)... 2015 The Canadian International Pharmacy ... Canadian Anti-Fraud Centre (CAFC), continues to aggressively ... CIPA verification seal on illegitimate pharmacy websites.  The ... pharmacy member companies who have maintained a 100% ... than 10 million Americans since 2002. ...
(Date:7/28/2015)... Mass., July 28, 2015   Cynosure, Inc. ... and markets medical devices for aesthetic procedures and ... for the three months ended June 30, 2015. ... quarter of double-digit growth, as revenues increased 47 ... Cynosure Chief Executive Officer Michael Davin. "While our ...
Breaking Medicine Technology:Global Hearing Aids Market 2015-2019 with G N Store Nord, Sonova Holdings & William Demant Dominating 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 3Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 2Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 3Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 4Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 5Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 6Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 7Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 8Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 9Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 10Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 11Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 12Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 13
... Jan. 25, 2011 Reportlinker.com announces that a new ... European Markets for Assisted Living Technologies ... This study discusses the European markets for assisted ... growth. There is a note on competitive and technology ...
... Reportlinker.com announces that a new market research report is ... Products for Urology Procedures in the Indian Market ... This Market Engineering research service has been developed to ... covers the Urology markets. This research service presents the ...
Cached Medicine Technology:
(Date:7/28/2015)... ... July 28, 2015 , ... ... Obama’s visit to Ethiopia to learn more about the impact of U.S. collaborations ... This initiative focuses on accelerating agricultural development as an engine of broad-based economic ...
(Date:7/28/2015)... ... 16, 2015 (PRWEB) July 28, 2015 , ... Nations Insurance ... insurance quotes to its clients, recently announced the launch of Commercial, Auto and ... their specific needs. , Liability automobile insurance policies are one popular type ...
(Date:7/28/2015)... ... 2015 , ... Women in Technology (WIT), the premier organization contributing to the ... has selected Lisa Dezzutti, CEO and president at Market Connections, Inc. as the organization’s ... this organization that empowers women to thrive and excel in the technology field. In ...
(Date:7/28/2015)... ... July 28, 2015 , ... Dr. Aziz Ahmad recently ... talk took place from noon to 1 p.m. Tuesday, June 23, at the Gulf ... , Dr. Ahmad is board-certified in colorectal surgery and has more than 35 ...
(Date:7/28/2015)... ... July 28, 2015 , ... OrthAlign, Inc., ... its ORTHALIGN PLUS® system, a palm-sized, single-use navigation device for Total Hip Arthroplasty ... precision with practicality in a revolutionary way for Total Knee Arthroplasty surgeries and ...
Breaking Medicine News(10 mins):Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:Nations Insurance Solutions Announces Auto, Motorcycle, and Commercial Business Insurance Quotes. 2Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3
... blood sugar disease help cause malignancy, or just share ... -- People with diabetes may have something else to ... according to a new consensus report produced by experts ... American Diabetes Association. , Diabetes, primarily type 2 ...
... ... first SottoPelle® medical clinic in Middle Tennessee. Dr. Tutera is a pioneer in an ... levels to authentically regulate the release of hormones. , ... Nashville, Tenn. (PRWEB) June 16, 2010 -- Gino ...
... ... health and fitness fun for the whole family. Free to download with $.99 in-app purchase ... best streetball players and ball handlers. , ... Los Angeles, CA (PRWEB) June 16, 2010 -- Luis Da Silva Jr. aka ...
... , ... insurance with no payout limits and is the first in the industry to do so. ... (Vocus) June 16, 2010 ... a “No Dollar Limit” provision for their policy, an industry first. All pet insurance ...
... consensus statement of experts assembled by the American ... emerging evidence that suggests cancer incidence is associated ... factors and treatments. The new report reviews the ... and cancer incidence/prognosis; risk factors common to both ...
... PITTSBURGH, June 9 Widespread geographic variations exist in drug ... much as others, according to a University of Pittsburgh Graduate ... June 9 issue of the New England Journal of ... under Medicare, the study also found that higher spending on ...
Cached Medicine News:Health News:Scientists Tease Out Links Between Diabetes, Cancer 2Health News:Scientists Tease Out Links Between Diabetes, Cancer 3Health News:Gino Tutera, M.D., F.A.C.O.G. Brings SottoPelle Therapy to Middle Tennessee, Opens Practice in Nashville Medical District 2Health News:Trikz Streetball Basketball iTunes App Promotion: Only $.99 to Unlock All Content for the iPhone, iPod Touch, and iPad 2Health News:Trikz Streetball Basketball iTunes App Promotion: Only $.99 to Unlock All Content for the iPhone, iPod Touch, and iPad 3Health News:Trupanion Announces an Industry First in Pet Insurance 2Health News:Trupanion Announces an Industry First in Pet Insurance 3Health News:Experts explore emerging evidence linking diabetes and cancer 2Health News:Experts explore emerging evidence linking diabetes and cancer 3Health News:Vast geographic differences found in drug spending under Medicare 2
... The TandemHeart PTVA ( Percutaneous ... unique proprietary solution for the hemodynamic needs ... Cardiologists and Cardiac Surgeons. These specialists ... provide some coronary artery perfusion, but the ...
Datascope presents a unique new product for post-hemostasis puncture site management. Safeguard is the first product ever to combine a built-in inflatable bulb and a sterile dressing- providing adjus...
... Line catheter is inserted into the subclavian ... superior vena cava. The Cool Line ... sterile, temperature-controlled saline flowing within a closed-loop ... central circulation. The Cool Line combines ...
...
Medicine Products: